238 related articles for article (PubMed ID: 17110336)
21. Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1).
Dai C; Shi D; Gu W
J Biol Chem; 2013 Jul; 288(27):19581-92. PubMed ID: 23677994
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors.
Lai Z; Yang T; Kim YB; Sielecki TM; Diamond MA; Strack P; Rolfe M; Caligiuri M; Benfield PA; Auger KR; Copeland RA
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14734-9. PubMed ID: 12407176
[TBL] [Abstract][Full Text] [Related]
23. Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
Wang Q; Yang Y; Wang L; Zhang PZ; Yu L
Biochem Biophys Res Commun; 2008 Sep; 374(3):437-41. PubMed ID: 18638452
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation.
Jin YH; Jeon EJ; Li QL; Lee YH; Choi JK; Kim WJ; Lee KY; Bae SC
J Biol Chem; 2004 Jul; 279(28):29409-17. PubMed ID: 15138260
[TBL] [Abstract][Full Text] [Related]
25. Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress.
Lee JH; Jeong MW; Kim W; Choi YH; Kim KT
J Biol Chem; 2008 Jul; 283(28):19826-35. PubMed ID: 18490454
[TBL] [Abstract][Full Text] [Related]
26. DNA damage activates p53 through a phosphorylation-acetylation cascade.
Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
[TBL] [Abstract][Full Text] [Related]
27. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
Nguyen DX; Baglia LA; Huang SM; Baker CM; McCance DJ
EMBO J; 2004 Apr; 23(7):1609-18. PubMed ID: 15044952
[TBL] [Abstract][Full Text] [Related]
28. The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability.
D'Arcy P; Maruwge W; Ryan BA; Brodin B
Mol Cancer Res; 2008 Jan; 6(1):127-38. PubMed ID: 18234968
[TBL] [Abstract][Full Text] [Related]
29. The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis.
Huang J; Xu LG; Liu T; Zhai Z; Shu HB
FEBS Lett; 2006 Feb; 580(3):940-7. PubMed ID: 16427630
[TBL] [Abstract][Full Text] [Related]
30. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation.
Legube G; Linares LK; Lemercier C; Scheffner M; Khochbin S; Trouche D
EMBO J; 2002 Apr; 21(7):1704-12. PubMed ID: 11927554
[TBL] [Abstract][Full Text] [Related]
31. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
32. Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode.
Wang D; Kon N; Lasso G; Jiang L; Leng W; Zhu WG; Qin J; Honig B; Gu W
Nature; 2016 Oct; 538(7623):118-122. PubMed ID: 27626385
[TBL] [Abstract][Full Text] [Related]
33. SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.
Lu YF; Xu XP; Lu XP; Zhu Q; Liu G; Bao YT; Wen H; Li YL; Gu W; Zhu WG
Oncogene; 2020 Jun; 39(24):4650-4665. PubMed ID: 32404984
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.
Espinosa JM; Emerson BM
Mol Cell; 2001 Jul; 8(1):57-69. PubMed ID: 11511360
[TBL] [Abstract][Full Text] [Related]
35. The contribution of the RING finger domain of MDM2 to cell cycle progression.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
[TBL] [Abstract][Full Text] [Related]
36. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription.
Faiola F; Liu X; Lo S; Pan S; Zhang K; Lymar E; Farina A; Martinez E
Mol Cell Biol; 2005 Dec; 25(23):10220-34. PubMed ID: 16287840
[TBL] [Abstract][Full Text] [Related]
37. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
[TBL] [Abstract][Full Text] [Related]
38. Making sense of ubiquitin ligases that regulate p53.
Jain AK; Barton MC
Cancer Biol Ther; 2010 Oct; 10(7):665-72. PubMed ID: 20930521
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
Somasundaram K; El-Deiry WS
Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
[TBL] [Abstract][Full Text] [Related]
40. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
